Evidence map›Paper›PMID 37630398›Full record

ArticleMolecules (Basel, Switzerland)2023

Novel Derivatives of Nitrobenzofurazan with Chromogenic and Fluorogenic Properties.

Alexandru Bujor, Anamaria Hanganu, Rodica Baratoiu, Elena N Hristea, Madalina Tudose, Victorita Tecuceanu, Augustin M Madalan, Petre Ionita

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alexandru BujorDepartment of Inorganic, Organic Chemistry, Biochemistry and Catalysis, Faculty of Chemistry, University of Bucharest, 90 Panduri, 050663 Bucharest, Romania.
Anamaria HanganuDepartment of Inorganic, Organic Chemistry, Biochemistry and Catalysis, Faculty of Chemistry, University of Bucharest, 90 Panduri, 050663 Bucharest, Romania.ORCID 0000-0002-0433-752X
Rodica BaratoiuInstitute of Physical Chemistry, Spl. Independentei 202, 060023 Bucharest, Romania.
Elena N HristeaInstitute of Physical Chemistry, Spl. Independentei 202, 060023 Bucharest, Romania.
Madalina TudoseInstitute of Physical Chemistry, Spl. Independentei 202, 060023 Bucharest, Romania.ORCID 0000-0002-9173-0249
Victorita TecuceanuInstitute of Organic and Supramolecular Chemistry, Spl. Independentei 202B, 060023 Bucharest, Romania.
Augustin M MadalanDepartment of Inorganic, Organic Chemistry, Biochemistry and Catalysis, Faculty of Chemistry, University of Bucharest, 90 Panduri, 050663 Bucharest, Romania.
Petre IonitaDepartment of Inorganic, Organic Chemistry, Biochemistry and Catalysis, Faculty of Chemistry, University of Bucharest, 90 Panduri, 050663 Bucharest, Romania.ORCID 0000-0002-2216-3842

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Five new derivatives were obtained utilizing 4-chloro-7-nitrobenzofurazan (NBD-chloride) in combination with furfurylamine, adamantylamine, aminohippuric acid, phenylalanine, and dehydroabietylamine. These derivatives were then subjected to a comparative analysis of their physical, chemical, and certain biological properties alongside two analogous and known compounds derived from the glycine and 4-amino-TEMPO free radical.

Indexed as

fluorescenceNBDsynthesis

Identifiers

PMID37630398
PMCPMC10459551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.